About / Company Overview

The infrastructure to deliver complex care anywhere

Founded in Edinburgh in 2014 and headquartered in Boston, Current Health gives health systems, community practices, and pharma and biotech companies the safety, operating, and evidence infrastructure to deliver advanced therapies and acute care beyond the hospital.

Our mission

Making advanced treatments accessible and sustainably affordable at scale

To be the industry's premier safety, operating, and evidence infrastructure for making transformative advanced treatments accessible and sustainably affordable at scale.

Advanced therapies like CAR-T, bispecifics, and cell and gene therapies are transforming medicine, offering cures where none existed before. But these high-cost treatments often require extended inpatient stays and are only available at select academic medical centers. We're building the infrastructure to help make these emerging therapies more accessible to the patients who need them. By enabling safe ambulatory and home-based delivery, we expand access, reduce costs, and improve the patient experience, all while preserving the highest standards of safety and care quality.

Our vision

A world where life-saving advanced therapies are accessible to every patient who needs them, regardless of where they live.

Our story

A decade of shifting care from hospitals to homes

2014

Current Health founded in Edinburgh with a mission to deliver a safe, sustainable way to provide acute care at home. Built FDA-cleared technology and clinical infrastructure from the ground up.

2019

Expanded to the United States, landing partnerships with leading health systems and global pharma companies. Established research-based credibility with peer-reviewed publications.

2021

Became the largest provider of hospital at home technology and services in the United States.

2023

Partnered with Sarah Cannon to launch the largest multisite outpatient CAR-T program.

2025

Market leader in outpatient and community CAR-T, bispecific, and advanced therapy enablement. Landed strategic partnerships with global pharma companies.

What we stand for

Our principles

Make providers' lives easier

We build infrastructure that reduces burden, not adds to it.

Make patients' lives easier

Recover at home with family, not in a hospital bed.

Make advanced treatments accessible

Bring life-saving therapies closer to where patients live.

Make programs economically viable

Sustainable economics for everyone.

Regulatory and compliance

Cleared, compliant, and built for regulated care

Our platform is a regulated medical device, and our clinical team handles protected health information every day, for health systems, practices, and trial sponsors.

FDA-cleared

The Current Health System is an FDA-cleared Class II physiological monitoring system, with five 510(k) clearances since 2019, most recently in 2023.

CE marked

CE marked as a Class IIa medical device for use across EU member states.

Trial-ready data

Trial data delivered to your EDC with 21 CFR Part 11 audit trails.

HIPAA compliant

Protected health information handled in line with US healthcare data privacy and security requirements.

ISO 13485

Quality management system certification for medical device design and manufacturing.

SOC 2 Type 2 and ISO 27001

Third-party validated security controls for data protection and operational integrity.

Where we work

A global presence

US headquarters

Boston, Massachusetts

Commercial, clinical operations, and customer success

Engineering and product

Edinburgh, Scotland

Platform development, device engineering, and data science

Leadership

Leadership team

Chris McGhee, CEO and Co-founder

Chris McGhee

CEO and Co-founder

Matt Wilkes, MD, PhD, Chief Medical Officer

Matt Wilkes, MD, PhD

Chief Medical Officer

Hope Smith, Chief Operating Officer

Hope Smith

Chief Operating Officer

John McLean, Chief Financial Officer

John McLean

Chief Financial Officer

Christopher Pilkington, Chief Strategy Officer

Christopher Pilkington

Chief Strategy Officer

Matthew Stark, SVP of Commercial Growth

Matthew Stark

SVP of Commercial Growth

Dani Armstrong, VP of Product

Dani Armstrong

VP of Product

Tom Halfpenny, VP of R&D

Tom Halfpenny

VP of R&D

Craig O'Neil

VP of Engineering

Katie Green, VP of Marketing

Katie Green

VP of Marketing

Tell us what you're working on

We'll help you find the right starting point, whether you're shortening length of stay or scaling full outpatient delivery.

Talk to our team